Methyl 4-((tert-butoxycarbonyl)amino)piperidine-4-carboxylate hydrochloride
95%
- Product Code: 76305
CAS:
1381947-68-7
| Molecular Weight: | 294.77 g./mol | Molecular Formula: | C₁₂H₂₃ClN₂O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD20527368 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, store under inert gas |
Product Description:
This compound is primarily used in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the preparation of various biologically active molecules, including those targeting neurological disorders and cardiovascular diseases. Its structure, featuring both a tert-butoxycarbonyl (Boc) protecting group and a carboxylate ester, makes it valuable in peptide and organic synthesis, where selective deprotection and functionalization are required. Additionally, it is employed in the research and development of novel drug candidates, aiding in the exploration of structure-activity relationships (SAR) to optimize therapeutic efficacy.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | ฿4,401.00 |
+
-
|
| 1.000 | 10-20 days | ฿10,998.00 |
+
-
|
| 5.000 | 10-20 days | ฿33,093.00 |
+
-
|
Methyl 4-((tert-butoxycarbonyl)amino)piperidine-4-carboxylate hydrochloride
This compound is primarily used in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the preparation of various biologically active molecules, including those targeting neurological disorders and cardiovascular diseases. Its structure, featuring both a tert-butoxycarbonyl (Boc) protecting group and a carboxylate ester, makes it valuable in peptide and organic synthesis, where selective deprotection and functionalization are required. Additionally, it is employed in the research and development of novel drug candidates, aiding in the exploration of structure-activity relationships (SAR) to optimize therapeutic efficacy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :